Codexis to Present at 2013 UBS Global Healthcare Conference

  Codexis to Present at 2013 UBS Global Healthcare Conference

2013 UBS Global Healthcare Conference

Business Wire

REDWOOD CITY, Calif. -- May 14, 2013

Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for
pharmaceutical, biofuel and chemical production, today announced that John
Nicols, President and CEO of Codexis, will present a company overview at the
2013 UBS Global Healthcare Conference on Monday, May 20, 2013 at 3:00 p.m. ET
in New York City.

A live webcast and replay will be available on the Investors section of the
company's website, http://ir.codexis.com/.

About Codexis, Inc.

Codexis, Inc. engineers enzymes for pharmaceutical, biofuel and chemical
production. Codexis’ proven technology enables scale-up and implementation of
biocatalytic solutions to meet customer needs for rapid, cost-effective and
sustainable process development – from research to manufacturing. For more
information, see www.codexis.com.

Contact:

Codexis, Inc.
Investors
Paul Cox, 212-362-1200
ir@codexis.com
or
Media
Jemma Connor, +44 161 359 3255
jemma.connor@notchcommunications.co.uk
 
Press spacebar to pause and continue. Press esc to stop.